These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 20002704)

  • 1. Effect of pantoprazole in patients with chronic laryngitis and pharyngitis related to gastroesophageal reflux disease: clinical, proximal, and distal pH monitoring results.
    Karoui S; Bibani N; Sahtout S; Zouiten L; Kallel L; Matri S; Serghini M; Ben Mustapha N; Boubaker J; Besbes G; Filali A
    Dis Esophagus; 2010 May; 23(4):290-5. PubMed ID: 20002704
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictors of acid suppression success in patients with chronic laryngitis.
    Wang AJ; Liang MJ; Jiang AY; Lin JK; Xiao YL; Peng S; Chen J; Wen WP; Chen MH
    Neurogastroenterol Motil; 2012 May; 24(5):432-7, e210. PubMed ID: 22276941
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proton-pump inhibitors in sleep-related breathing disorders: clinical response and predictive factors.
    Modolell I; Esteller E; Segarra F; Mearin F
    Eur J Gastroenterol Hepatol; 2011 Oct; 23(10):852-8. PubMed ID: 21811158
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Gastroesophagopharyngeal reflux in infants and children with recurrent symptoms of the upper respiratory tract].
    Semeniuk J; Kaczmarski M; Sidor K; Krasnow A; Daniluk U; Matuszewska E
    Pol Merkur Lekarski; 2004 May; 16(95):461-4. PubMed ID: 15518427
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Proximal gastro-esophageal reflux monitoring in patients with suspected laryngopharyngeal reflux disease].
    Karoui S; Zouiten L; Serghini M; Sahtout-Jouini S; Matri S; Kallel L; Boubaker J; Filali A
    Tunis Med; 2008 Aug; 86(8):735-9. PubMed ID: 19472757
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of pantoprazole on the course of reflux-associated laryngitis: a placebo-controlled double-blind crossover study.
    Eherer AJ; Habermann W; Hammer HF; Kiesler K; Friedrich G; Krejs GJ
    Scand J Gastroenterol; 2003 May; 38(5):462-7. PubMed ID: 12795454
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Diagnostic and treatment algorithm for pharyngolaryngeal reflux].
    Voineag M; Drug V; Indrei LL; Cobzeanu MD
    Rev Med Chir Soc Med Nat Iasi; 2011; 115(2):405-11. PubMed ID: 21870732
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Chronic pharyngitis and laryngitis caused by gastroesophageal reflux].
    Tanabe T; Oridate N
    Nihon Rinsho; 2016 Aug; 74(8):1367-1371. PubMed ID: 30562444
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Optimal diagnostic criteria of ENT manifestations of GERD].
    Morozov SV; Gibadullina LV; Isakova VA; Svistushkin VM
    Eksp Klin Gastroenterol; 2011; (8):8-18. PubMed ID: 22629749
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of patients of chronic laryngitis with and without troublesome reflux symptoms.
    Wang AJ; Liang MJ; Jiang AY; Lin JK; Xiao YL; Peng S; Chen J; Wen WP; Chen MH
    J Gastroenterol Hepatol; 2012 Mar; 27(3):579-85. PubMed ID: 21793907
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of pH-impedance testing to evaluate patients with suspected extraesophageal manifestations of gastroesophageal reflux disease.
    Malhotra A; Freston JW; Aziz K
    J Clin Gastroenterol; 2008 Mar; 42(3):271-8. PubMed ID: 18223497
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gastro-oesophageal reflux disease in chronic laryngitis: prevalence and response to acid-suppressive therapy.
    Qua CS; Wong CH; Gopala K; Goh KL
    Aliment Pharmacol Ther; 2007 Feb; 25(3):287-95. PubMed ID: 17269990
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The laryngological complications of the Gastroesophageal Reflux Diseases].
    Skrodzka D; Wereszczyńska-Siemiatkowska U; Południewska B; Kasprowicz JB
    Przegl Lek; 2006; 63(9):752-5. PubMed ID: 17479863
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictors of outcome in an open label, therapeutic trial of high-dose omeprazole in laryngitis.
    Williams RB; Szczesniak MM; Maclean JC; Brake HM; Cole IE; Cook IJ
    Am J Gastroenterol; 2004 May; 99(5):777-85. PubMed ID: 15128336
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Sleep disorders in patients with gastroesophageal reflux disease: an open clinical and pH metric prospective study].
    Karoui S; Chtara O; Bibani N; Kallel L; Zouiten L; Matri S; Serghini M; Boubaker J; Filali A
    Tunis Med; 2010 Mar; 88(3):172-7. PubMed ID: 20415190
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of pantoprazole on duodeno-gastro-esophageal reflux (DGER).
    Kunsch S; Neesse A; Linhart T; Steinkamp M; Fensterer H; Adler G; Gress TM; Ellenrieder V
    Z Gastroenterol; 2009 Mar; 47(3):277-82. PubMed ID: 19280541
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prospective evaluation of duodenogastroesophageal reflux in gastroesophageal reflux disease patients refractory to proton pump inhibitor therapy.
    Kunsch S; Neesse A; Linhart T; Nell C; Gress TM; Ellenrieder V
    Digestion; 2012; 86(4):315-22. PubMed ID: 23128301
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ninety-six-hour wireless oesophageal pH monitoring following proton pump inhibitor administration in NERD patients.
    Calabrese C; Liguori G; Gabusi V; Gionchetti P; Rizzello F; Straforini G; Brugnera R; Di Febo G
    Aliment Pharmacol Ther; 2008 Jul; 28(2):250-5. PubMed ID: 18485128
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predicting the efficacy of proton pump inhibitors in patients with non-erosive reflux disease before therapy using dual-channel 24-h esophageal pH monitoring.
    Shimatani T; Sugimoto M; Nishino M; Adachi K; Furuta K; Ito M; Kurosawa S; Manabe N; Mannen K; Hongo M; Chiba T; Kinoshita Y;
    J Gastroenterol Hepatol; 2012 May; 27(5):899-906. PubMed ID: 22098590
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Findings of 24-hour esophageal pH monitoring in patients with respiratory and otorhinolaryngologic manifestations of gastroesophageal reflux disease].
    Karoui S; Zouiten L; Matri S; Boubaker J; Filali A
    Tunis Med; 2006 Mar; 84(3):165-9. PubMed ID: 16755957
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.